(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhex-5-enoic acid, 95.0%, 100mg

5,10,15,20-Tetrakis(4-(1,3,2-dioxaborinan-2-yl)phenyl)porphyrin, 98%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 97%, 1g

Metoclopramide>98.0%(GC)(T)5g

Methyl 3-(4-Methoxycarbonylphenyl)propionate>97.0%(T)25g

Sodium formate-d, 10g

2-Bromopropionic Acid>98.0%(GC)(T)500g

tert-Butyl n-[(1S)-1-(hydrazinecarbonyl)ethyl]carbamate, 95+%, 5g

(6R,7R)-7-Amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 5g

7-HEXADECANONE, 95%, 1g

4'-Cyanobiphenyl-4-yl trans-4-propylcyclohexanecarboxylate, 97.0%, 5g

Methyl 3-Bromopyrazine-2-carboxylate, 97.0%, 25g

5-Fluoropyrimidine-4,6-diol, 95.0%, 250mg